Summary -   A new market study, titled “Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential” has been featured on Wise Guy Reports.The global market size for human vaccines is anticipated to observe tremendous growth projections during 2019 – 2025.The prominent factors that are expected to contribute to the growth of the global human vaccines market during the forecast period: ALSO READ: https://icrowdnewswire.com/2019/11/05/human-vaccines-market-segmentation-parameters-and-prospects-2019-to-2025-market-research-report/ Increased Disease AwarenessApproval/launches of the New VaccinesRising focus on immunization programsIncreasing government support for the vaccine development Highlighted with 35 tables and 140 figures, this 310-page report “Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential” provides a comprehensive analysis of the fast-evolving, high-growth global human vaccines market.The report offers the most up-to-date industry data on the actual market situation and future outlook for the global human vaccines market.The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.Key trends in terms of collaboration, partnerships, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details.The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2025.
Summary – A new market study, “Global and Japan Zika Virus Vaccines Market Insights, Forecast to 2026”has been featured on WiseGuyReports.Zika Virus Vaccines market is segmented by region (country), players, by Type, and by Application.Players, stakeholders, and other participants in the global Zika Virus Vaccines market will be able to gain the upper hand as they use the report as a powerful resource.The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.Also Read: https://www.marketwatch.com/press-release/zika-virus-vaccines-2020-global-market-outlookresearchtrends-and-forecast-to-2026-2020-09-11Segment by Type, the Zika Virus Vaccines market is segmented intoDNA VaccineInactivated VaccinePurified Inactivated VaccineTable of Contents Segment by Application, the Zika Virus Vaccines market is segmented intoHospitalsClinicsAcademic and ResearchOthers Regional and Country-level AnalysisThe Zika Virus Vaccines market is analysed and market size information is provided by regions (countries).The key regions covered in the Zika Virus Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa.It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.The report includes country-wise and region-wise market size for the period 2015-2026.It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.Competitive Landscape and Zika Virus Vaccines Market Share AnalysisZika Virus Vaccines market competitive landscape provides details and data information by players.
Having much of the earth often with lockdown or maybe looking at a forthcoming get back to the item, it might be pardoned it is bated breath of air the way it awaits announcement messages with almost any very little advance of which had been manufactured to making a vaccine intended for Covid-19.A task which often often takes ages seems to obtain also been pared because of some sort of scramble spanning a make any difference connected with many weeks, and many 240 likely vaccines usually are at this time within progress in various sites across the world, as well as 45 with professional medical demos in addition to being unfaithful from the remaining development connected with examining.Intended for health systems in addition to the methodical advisors many keeping some sort of weary feel connected with folks that include be depleted connected with thoughts, some sort of vaccine will undoubtedly be this holy grail from the combat with Covid.Completely new rules made usually are often prefaced while using the text "until we have now some sort of vaccine".Certainly completely new vaccines will not generally do the job, in addition to it's the same needed to noise this essential notice connected with careful attention.Although if it turns out a minimum of one may, what exactly, genuinely, is best we can easily be expecting from using it?Usually are most of us wanting too much of some sort of vaccine?Assumptions are usually manufactured that your vaccine would be the panacea that'll eventually consign this common SARS-CoV-2 to help heritage.Although usually are most of us quite possibly wanting too much of the item, at the very least from the early stages?In the field of drugs we have a principle termed "sterilising immunity", whereby some sort of vaccinated specific can expect entire safeguard at a disease.
10
Market Highlights:Veterinary Pain Management Market Size is growing rapidly and pervasively mainly due to the spreading awareness towards animal care.People are generally compassionate towards their pets, and they are increasingly becoming aware of animal physiology and psychology and the pain they go through during sickness, injuries, recoveries and after effects of the diseases.Besides, factors such as the increasing number of pet owners and the strengthening bond between owners and their animal companions escalate the market on the global heights.Get Sample PDF @https://www.marketresearchfuture.com/sample_request/5961Acknowledging the rapid expansions, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global veterinary pain management market will reach significant growth heights by 2023 registering 8.2% CAGR during the review period (2018 – 2023).Additional factors substantiating the market growth include the rising per capita income that is leading to increasing the pet adoptions and the trend of nuclear families.Increased awareness concerning animal cruelty is influencing people’s ideologies and knowledge about animals.Moreover, developments in animal health medicines and vaccines, along with the increased medical treatments are fostering the market growth of veterinary pain management market.are contributing to the market growth.Improving economic conditions worldwide foster market growth, enabling access to the quality of life, increasing consumers’ buying power, and availing cost-effective veterinary healthcare.On the other hand, factors such as the lack of awareness and knowledge pertaining to the animal well-being and the rising cost of pet care, etc.Also, technological innovations in the field of veterinary surgical instruments are acting as a tailwind pushing up the market growth in the region.
Summary - A new market study, titled “Global Biodefense Market Research Report 2020”has been featured on WiseGuy Reports.Global biodefense market will reach $15.85 billion by 2030, growing by 6.2% annually over 2020-2030 owing to the rising need for military and civilian vaccines and equipment against diseases including COVID-19 pandemic.Highlighted with 84 tables and 73 figures, this 165-page report “Global Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global biodefense market and all its sub-segments through extensively detailed classifications.Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain.The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
SummaryA new market study, titled “Global Vaccines Market - 2019-2026” has been featured on WiseGuyReports.Vaccines are biological products, acquired immunity to a particular disease or these products protect people from severe and dreadful diseases.The emerging infectious diseases include Middle East respiratory syndrome coronavirus (MERS-CoV), meningococcal disease, Ebola, avian flu, swine flu and most recently zika virus.According to WHO in 2017, the annual epidemics in seasonal influenza globally estimated that 3-5 million cases of severe illness and about 290,000-600,000 respiratory deaths are observed.According to Centre Of Disease Control And Prevention in 2016, there were about 360 total cases of meningococcal disease reported and most among the children below one year old followed by adults.ALSO READ:  https://www.medgadget.com/2020/07/vaccines-2020-global-market-analysis-company-profiles-industrial-overview-research-report-size-segmentation-opportunities-coronavirus-covid-19-impact-analysis-forecasting-to-2026.htmlMarket Segmentation By Vaccines Type The global vaccines market is segmented on vaccines type which includes influenza, measles, smallpox, yellow fever, hepatitis A, polio, shingles, and others.By geography North America dominates the global vaccines market in 2018, due to the increase in seasonal influenza viruses around the year in the U.S and government funding for research on effective vaccines.
Summary - A new market study, titled “Global Veterinary Healthcare Market: By Product Type (Drugs (Antibiotics, Antifungal, Ectoparasiticides, Endoparacitides, Endectoparaciticides, Anti-inflammatory Drugs, Drugs for Chronic Diseases, and Others), Vaccines, and Feed Additives (Nutritional Feed Additives and Medicinal Feed Additives)), By Animal Type (Farm Animals (Livestock, Poultry, Swine, and Equine) Companion Animals (Feline, Canine, and Avian), and Aquaculture), By Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Veterinary Pharmacies, Veterinary Hospitals, Veterinary Clinics, and E-Commerce), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023” has been featured on WiseGuyReports.Global Veterinary/Animal Healthcare Market Report Description:Veterinary/Animal healthcare market report gives comprehensive outlook on veterinary/animal healthcare market across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA).This report studies veterinary/animal healthcare market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.In addition, veterinary/animal healthcare market report includes animal demographics; regulatory scenario, top meat producing countries, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.Key stakeholders of the veterinary/animal healthcare market report include suppliers, manufacturers, marketers, policy makers, and veterinary healthcare service providers engaged in manufacturing and supply of veterinary/animal healthcare products.Global Veterinary/Animal Healthcare Market:The veterinary/animal healthcare market estimated to be valued US$ 35.8 Bn in 2017 and poised to grow at CAGR of 4.7% over 2017-2023.Market for Veterinary/Animal Healthcare projected to reach US$ 47.1 Bn by 2023 due to increased adoption of companion animals in emerging and developed countries and rising consumption of meat across the globe.Rising pet adoption and meat consumption expected drive animal healthcare marketThe rising adoption of companion animals in emerging countries and increasing consumption of meat for dietary needs expected to fuel the market for animal healthcare products over the forecast period.Apart from aforementioned dynamics, factors like increased instances of disease outbreaks in animals, and large scale production of animals in the form of factory farming expected to boost the animal healthcare market.
Summary - A new market study, titled “Global Injectable Drugs Market 2017-2021 ” has been featured on WiseGuyReports.Injectable drugs are directly infused into the body with the help of a syringe and a hollow needle.The market encompasses drugs that are used for the prevention and cure of various diseases, and are mainly of two types, namely, biologics and small molecule drugsALSO READ: https://www.newsmaker.com.au/news/379725/injectable-drugs-industry-treatment-outlook-analysis-research-review-to-2025#.X4V5_NAzaM8Technavio’s analysts forecast the global injectable drugs market to grow at a CAGR of 8.21% during the period 2017-2021.Covered in this report The report covers the present scenario and the growth prospects of the global injectable drugs market for 2017-2021.To calculate the market size, the report considers the sales of vaccines, branded, generic, and off-label drugs.The market is divided into the following segments based on geography: • Americas • APAC • EMEATechnavio's report, Global Injectable Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts.The report covers the market landscape and its growth prospects over the coming years.The report also includes a discussion of the key vendors operating in this market.Key vendors • AbbVie • F. Hoffmann-La Roche • GlaxoSmithKline • SanofiOther prominent vendors • Bayer • Bristol-Myers Squibb • Merck • Takeda Pharmaceutical • Teva PharmaceuticalMarket driver • Escalation in demand for self-injection devices • For a full, detailed list, view our reportMarket challenge • High cost of production • For a full, detailed list, view our reportMarket trend • Increase in industry-academia collaboration • For a full, detailed list, view our reportKey questions answered in this report • What will the market size be in 2020 and what will the growth rate be?• What are the market opportunities and threats faced by the key vendors?
1
Summary - A new market study, titled “Global Infectious Vaccines Market Insights and Forecast to 2026 ” has been featured on WiseGuyReports.The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026ALSO READ: https://www.einpresswire.com/article/522090998/infectious-vaccines-market-by-technology-share-demand-growth-opportunity-projection-analysis-forecast-outlook-2026Segment by Type, the Infectious Vaccines market is segmented into Preventive vaccine Therapeutic vaccineSegment by Application, the Infectious Vaccines market is segmented into Adults PediatricsRegional and Country-level Analysis The Infectious Vaccines market is analysed and market size information is provided by regions (countries).It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.The report includes country-wise and region-wise market size for the period 2015-2026.Competitive Landscape and Infectious Vaccines Market Share Analysis Infectious Vaccines market competitive landscape provides details and data information by players.The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020.
1
Summary - A new market study, titled “ Indian Influenza Market By Product Type (Vaxigrip, Influvac)-Forecast 2020 ” has been featured on WiseGuyReports.The Indian Influenza market has reported a remarkable growth in recent years, and is presenting ample opportunities to the industry’s players.With increasing pandemic as well as seasonal outbreak and rising awareness among people about these vaccines, the Indian influenza vaccine market is poised to scale newer acmes.Moreover, increasing disposable income, increasing incidences of influenza, introduction of new vaccines, entry of new players, and rising R investments are set to further boost the market’s growth.Owing to such factors, the Indian influenza market is anticipated to grow at a healthy CAGR during the forecast period (2015-2020).ALSO READ: https://www.einpresswire.com/article/526178093/india-influenza-2020-market-estimation-dynamics-outlook-research-trends-and-forecasts-to-2025In the report “IIndian Influenza Market By Product Type (Vaxigrip, Influvac)-Forecast 2020”, RNCOS analysts have endeavoured to address the current scenario of Indian influenza industry, factors favouring growth of the market, and the major roadblocks restraining the influenza vaccines market.Furthermore, the report provides the details about the distribution channel for influenza vaccines in the Indian industry.The latter half of the report provides competitive landscape including the market share of key players, such as Cipla Ltd., Bharat Biotech, Serum Institute of India, Abbott, Lupin Ltd, and others.
The report overtly defines the status of key players in the competitive landscape while including their portfolio and geographical expansion endeavors.Cell Culture Media Market: Information by Product Type (Reagents, Media (Classical Media, Stem Cell Media (Bone Marrow, Neural Stem Cells (NSCs), Mesenchymal Stem Cells (MSCs), Embryonic Stem Cells (ESCs) and others), Serum-Free Media and others) and Sera), Application (Biopharmaceutical, Tissue-Culture and Manufacturing, Gene Therapy, Cytogenetic and others), End User (Biopharmaceutical Companies, Academic and Research Laboratories, Hospitals and Diagnostic Centers and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) – Forecast till 2023Cell Culture Media Market Overview:Cell Culture Media Market is having a great run in the biotechnological sector owing to its prevalent use in the growth of microorganisms, cell lines, and cells.However, the traction it is getting is mostly from the healthcare sector where it is often used to develop vaccines.The global cell culture media market can have an imposing 9.1% CAGR during the forecast period (2017-2023).Over that period, it can also scale and surpass a valuation of USD 1290.1 million, reveals Market Research Future (MRFR).The report includes detailed segmental analysis and description of factors that can impact the market the most.These two regions have relatively less workforce and establishment cost, which is making them alluring in the eyes of market titans who are now expanding their business in the region.Cell Culture MediaMarket Segmental Analysis:The cell culture media market, for better comprehension and predictive analysis, can be segmented by type, application, and end-user.Based on type, the cell culture media market can be segmented into classical media, chemically defined media, protein-free media, lysogeny broth,serum-free media, and custom media.
The study has collectively presented refined data characterized by market valuation, SWOT analysis, market participants, regional segmentation, and revenue forecasts, enabling stakeholders to make logical business decisions.Generic Injectables Market Research Report, by Product Type (Monoclonal antibodies, Cytokines, Insulin, Vaccines), Container (Vials, Ampoules, Premix, Prefilled syringes), Application (Oncology, Anaesthesia, Anti-infectives, Cardiovascular), Distribution Channel (Hospital pharmacy, Retail pharmacy, Drug stores, Online stores) – Global Forecast Till 2023The global Generic Injectables Market is expected to exhibit a solid 13% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR).The global generic injectables market is mainly driven by the growing prevalence of noncommunicable diseases, which are mainly treated by injectables.The increasing prevalence of flu and other seasonal maladies has been a major driver for the generic injectables market.The growing effects of climate change are making seasonal maladies more severe, as more severe allergens and pathogens are being thrown up into the mix due to the shakeup caused by climate change.The increasing prevalence of cancer, AIDS, and other noncontagious diseases is also likely to be a major driver for the global generic injectables market over the forecast period.The use of generic injectables for treating cancer, in particular, is growing and is likely to play a key role in the global generic injectables market’s growth in the coming years.Growing research and drug development initiatives from government as well as nongovernmental medical research institutions is also likely to be a major driver for the global generic injectables market over the forecast period.
There's hope on the horizon!Pfizer, Moderna and AstraZeneca released the results of the clinical trials of their vaccine candidates over the past week.And all showing high efficacy.This has raised optimism that the pandemic may be nearing its end.Don’t take off your face masks yet, though.Because now the world will have to confront its next big challenge: distributing and administering the vaccine far and wide.And in as little time as possible.To remain potent, vaccines need to be stored in cold temperatures.This is a big challenge for governments and companies.So let's take a look at the cold chain network - particularly in India - and understand the opportunities and challenges faced by the sector.Click link to read: https://transfin.in/cold-chain-logistics-why-will-administering-the-pfizer-and-moderna-vaccines-be-a-challenge-for-india
The global peptide based cancer therapeutics market size is expected to reach USD 17.18 billion by 2027 according to a new study by Polaris Market Research.The report “Peptide Based Cancer Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Goserelin, Bortezomib, Leuprorelin, and Others); By Cancer Type (Lung, Breast, Colorectal, Prostrate, Skin, and Stomach Cancer); By Mode of Mechanism (Inhibitory, Necrosis Inducing, and Pro-Apoptotic Peptides), By Distribution Channel (Hospital, Retail, and Online Pharmacies), By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.Peptides are being widely used in therapeutics to treat several ailments, including cancer owing to their precision based nature, targeting solid tumor cells in the body.Peptide based cancer therapeutics have shown effective results against cancer as opposed to conventional cancer treatments, without much side effects.Peptide based therapies in the treatment of cancer are majorly classified as pure play peptide therapy, vaccines based on peptide, and peptide conjugate nanomaterials.Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/peptide-based-cancer-therapeutics-market/request-for-sampleThe factors propelling the market growth are the increasing prevalence of cancer across the world, cancer screening programs in emerging countries, and the high specificity of peptide based cancer vaccines.
The global immuno-oncology market size is expected to reach USD 38.89 billion by 2025 according to a new study by Polaris Market Research.The report “Immuno Oncology (I-O) Market Size, Trends, Industry Analysis By Treatment Approaches (Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines); By Novel Targets (IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i); By Tumor Types; By Region: Market Size & Forecast, 2020 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.Immuno-oncology, also called as cancer immunotherapy is a biologic treatment, which enhances the body’s natural defenses to stop the growth of cancer.The more precise targeting of patients for selected therapies is another important area of focus in oncology.Clinical biomarkers and pharmacogenomic studies are increasingly used to identify groups and sub-groups of patients most likely to benefit from an investigational agent in order to maximize its potential benefits.Moreover, rising number of ablation centers, surgical centers, and hospitals are driving the growth of tumor ablation market globally.The Report has also emphasized on the Oncolytic viruses, Neo-Antigen therapies, TCR Therapies and CAR-T therapies.
Astral Aviation has announced that it is ready to support the distribution of the recently discovered Covid-19 vaccines across its scheduled network of 15 destinations within Africa and a further 50 destinations available on charters with its fleet of 14 freighter aircrafts.
The department of health – Abu Dhabi, Etihad Cargo, Abu Dhabi Ports Group, Rafed and SkyCell launched Hope Consortium to handle more than six billion vaccine doses globally.The consortium represents a complete supply chain solution to address vaccine transport, demand planning, sourcing, training, and digital technology infrastructure, and facilitate vaccine availability across the world.The news follows Hope Consortium member Etihad Cargo and the consortium transporting five million vaccines in November on behalf of the department of health – Abu Dhabi.
Summary – A new market study, titled "Global Cancer Vaccines Market Insights and Forecast to 2026" has been featured on WiseGuyReports.Players, stakeholders, and other participants in the global Cancer Vaccines market will be able to gain the upper hand as they use the report as a powerful resource.The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.Also read – https://www.marketwatch.com/story/global-cancer-vaccines-market-analysis-2020-dynamics-trends-revenue-regional-segmented-outlook-forecast-till-2026-2020-08-24 Segment by Type, the Cancer Vaccines market is segmented intoPreventive Cancer VaccinesTherapeutic Cancer VaccinesSegment by Application, the Cancer Vaccines market is segmented intoCervical CancerProstate CancerOthersRegional and Country-level AnalysisThe Cancer Vaccines market is analysed and market size information is provided by regions (countries).The key regions covered in the Cancer Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa.It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.The report includes country-wise and region-wise market size for the period 2015-2026.It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.Competitive Landscape and Cancer Vaccines Market Share AnalysisCancer Vaccines market competitive landscape provides details and data information by players.The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020.
According to a new report published by Transparency Market Research (TMR)  titled “Veterinary Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”, the global veterinary molecular diagnostics market was valued at US$ 377.2 Mn in 2016 and is projected to expand at a CAGR of 8.6% from 2017 to 2025 to reach value of US$ 792.5 Mn by 2025.This report offers a thorough understanding of the global veterinary molecular diagnostics market including key trends, drivers, restraints, and opportunities.The Asia Pacific region is witnessing gradual adoption of new technologies in veterinary molecular diagnostics, increasing animal health care expenditure, and changing dynamics of the in vitro diagnostics industry.Factors indicating the growing importance of livestock diagnostics, medicines, and vaccines such as surging demand for improved nutrition (particularly, animal protein), limited natural resources, and widened focus on food safety are anticipated to boost the veterinary molecular diagnostics market during the forecast period.Request a Sample of Veterinary Molecular Diagnostics Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=42437Technological Advancements to drive Global MarketVeterinary molecular diagnostics offers several advantages over the conventional diagnostic techniques such as rapid turnaround time (2.5–3 hours), high test sensitivity and specificity, and better differentiation between avirulant and birulent strains.Pet owners are becoming more conscious about proper and timely diagnosis of disease suffered by their pets.However, high costs associated with these systems and assays presents a significant challenge for the market.Request for Analysis of COVID19 Impact on Veterinary Molecular Diagnostics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=42437Kits & Reagents Segment dominates the Market, followed by Instruments & Software SegmentThe global veterinary molecular diagnostics market has been segmented based on product, technology, animal type, disease indication, end-user, and geography.
 Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030.” The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.The study features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.Amongst other elements, the report includes:A detailed assessment of the current market landscape of drug developers engaged in the development of bispecific antibody therapeutics.A comprehensive analysis of novel technology platforms that are either currently available or being developed for the generation of bispecific antibody therapeutics.Detailed profiles of marketed and clinical stage (phase II and phase III) bispecific antibody therapeutics.Key takeaways from the bispecific antibody therapeutics pipeline.An analysis of the initiatives of big biopharma players engaged in this domain.An analysis of recent partnerships and collaboration agreements inked in bispecific antibody therapeutics domain.A review on the key steps involved and challenges associated with the manufacturing of bispecific antibodies.A clinical trial analysis of ongoing and planned studies related to bispecific antibody therapeutics.A review of the key promotional strategies that have been adopted by the developers of the marketed bispecific antibodies.A discussion on important, industry-specific trends, key market drivers and challenges, under a SWOT framework.A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)Target Disease Indication Autoimmune DisordersEye DisordersGenetic DisordersHematological MalignanciesInfectious DiseasesInflammatory DisordersSkin DisordersMechanism of ActionCytokines Retargeting / NeutralizationDual Ligands BlockingT-cell Retargeting / ActivationOthersTarget AntigensCD3 x CD19CD30 x CD16AFactor IXa x Factor XIL-1α x IL-1βIL-13 x IL-4IL-17A x AlbuminIL-17A x IL-17FPsl x PcrVTNF-α x HASVEGF-A x ANG2OthersAntibody FormatAsymmetricFragmentsSymmetricOthersKey Geographical Region North AmericaEuropeAsia-Pacific  Transcripts of interviews held with the following senior level representatives of stakeholder companies:Martin Steiner (Chief Executive Officer, Synimmune)Ludger Große-Hovest (Chief Scientific Officer, Synimmune)Jane Dancer (Chief Business Officer, F-Star)Siobhan Pomeroy (Senior Director, Business Development, Cytom X)Yinjue Wang (Associate Director, Process Development, Innovent Biologics) Key companies covered in the reportAmgenAblynxAbbVieAffibodyAffimedAlphamabAstraZenecaAvillionChugai PharmaceuticalsEddingpharmGSKMerckMerusRocheRegeneron PharmaceuticalsTaisho PharmaceuticalsZymeworks For more information please click on the following link:https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html Other Recent OfferingsGlobal Preventive Vaccines Market, 2020-2030Endocannabinoid System Targeted Therapeutics Market, 2019-2030Antibody Contract Manufacturing Market, 2020-2030 About Roots AnalysisRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry.The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.If you’d like help with your growing business needs, get in touch at [email protected] Contact InformationRoots Analysis Private LimitedGaurav Chaudhary+1 (415) 800 [email protected]  
1
More

Top